Literature DB >> 10750880

Clinically significant drug interactions.

P W Ament1, J G Bertolino, J L Liszewski.   

Abstract

A large number of drugs are introduced every year, and new interactions between medications are increasingly reported. Consequently, it is no longer practical for physicians to rely on memory alone to avoid potential drug interactions. Multiple drug regimens carry the risk of adverse interactions. Precipitant drugs modify the object drug's absorption, distribution, metabolism, excretion or actual clinical effect. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. Drugs with a narrow therapeutic range or low therapeutic index are more likely to be the objects for serious drug interactions. Object drugs in common use include warfarin, fluoroquinolones, antiepileptic drugs, oral contraceptives, cisapride and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Many other drugs, act as precipitants or objects, and a number of drugs act as both. Regularly updated manuals of drug interactions and CD-ROM-formatted programs are useful office references.

Entities:  

Mesh:

Year:  2000        PMID: 10750880

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  18 in total

Review 1.  Genetic diversity and new therapeutic concepts.

Authors:  Barkur S Shastry
Journal:  J Hum Genet       Date:  2005-07-23       Impact factor: 3.172

2.  Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study.

Authors:  Motiur Rahman; George Howard; Jingjing Qian; Kimberly Garza; Ash Abebe; Richard Hansen
Journal:  Res Social Adm Pharm       Date:  2020-02-20

3.  Psychotropic drugs and their impact on the treatment of paediatric dental patients.

Authors:  E Hajishengallis
Journal:  Eur Arch Paediatr Dent       Date:  2013-06-21

Review 4.  Drug Interactions in Neurocritical Care.

Authors:  Brian Spoelhof; Salia Farrokh; Lucia Rivera-Lara
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

5.  Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.

Authors:  Silvia-Regina Secoli; Albert Figueras; Maria Lúcia Lebrão; Fernão Dias de Lima; Jair Licio Ferreira Santos
Journal:  Drugs Aging       Date:  2010-09-01       Impact factor: 3.923

6.  Drug interaction and pharmacist.

Authors:  Ja Ansari
Journal:  J Young Pharm       Date:  2010-07

Review 7.  Secondary stroke prevention strategies for the oldest patients: possibilities and challenges.

Authors:  Cheryl D Bushnell; Cathleen S Colón-Emeric
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.

Authors:  William L Marshall; Hwa-Ping Feng; Luzelena Caro; Jennifer Talaty; Zifang Guo; Xiaobi Huang; Deborah Panebianco; Joanne Ma; Eric Mangin; Terry E O'Reilly; Joan R Butterton; Wendy W Yeh
Journal:  Eur J Clin Pharmacol       Date:  2017-02-24       Impact factor: 3.064

9.  Potentially inappropriate medications and medication combinations before, during and after hospitalizations: an analysis of pathways and determinants in the Swiss healthcare setting.

Authors:  Kevin Migliazza; Caroline Bähler; Daniel Liedtke; Andri Signorell; Stefan Boes; Eva Blozik
Journal:  BMC Health Serv Res       Date:  2021-05-28       Impact factor: 2.655

10.  Effect of anti-tuberculosis therapy on polymorphic drug metabolizing enzyme CYP2C9 using phenytoin as a probe drug.

Authors:  Melvin George; Deepak Gopal Shewade; Saka Vinod Kumar; Chandrasekaran Adithan
Journal:  Indian J Pharmacol       Date:  2012 Jul-Aug       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.